The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway
Qing Li, Jialuo He, Senlin Li, Cheng Tian, Jian Yang, Huimin Yuan, Yi Lu, Paolo Fagone, Ferdinando Nicoletti, Ming Xiang
Topics & Concepts
Immune systemPancreatic cancerCancer researchGemcitabineImmunotherapyDendritic cellImmunogenicityMedicineAdoptive cell transferImmunosuppressionTumor microenvironmentImmunologyChemotherapyPharmacologyT cellCancerInternal medicineImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction